Mode
Text Size
Log in / Sign up

FEES Dysphagia Index (FDI) derivation and validation in hospitalized neurological patients

FEES Dysphagia Index (FDI) derivation and validation in hospitalized neurological patients
Photo by Alexandra Vázquez / Unsplash
Key Takeaway
Consider the FDI-C as a bedside tool for dysphagia risk assessment in neurological inpatients, noting its observational validation.

This single-center, retrospective cohort study derived and validated the FEES Dysphagia Index (FDI) in two cohorts of hospitalized neurological patients (n=1,257 and n=1,686). The comparator was the Worst Penetration-Aspiration Scale (PAS) score. The primary outcome was FDI-C performance for clinical outcomes.

For hospital-acquired pneumonia, FDI-C had an AUC of 0.70 versus Worst PAS AUC of 0.60 (p<0.001). For mortality, FDI-C AUC was 0.71 versus Worst PAS AUC of 0.62 (p=0.040). For restricted oral intake, FDI-C AUC was 0.90 versus Worst PAS AUC of 0.74 (p<0.001). FDI-C mapped linearly onto ordinal FOIS values (proportional odds RCS p=0.99). It reconstructed clinician oral intake recommendations with AUC up to 0.93.

Safety and tolerability were not reported. Key limitations include retrospective design, single-center setting, and selection bias addressed but not eliminated. The study is observational; association does not imply causation.

Practice relevance is that FDI-C is a bias-resilient, bedside-calculable score for clinical decision support. However, generalizability beyond neurological inpatients is uncertain, and absolute risk reduction was not reported.

Study Details

Study typeCohort
Sample sizen = 1,257
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Multi-consistency testing during flexible endoscopic evaluation of swallowing (FEES) is clinically necessary but introduces selection bias: worst scores inflate severity because the number of consistencies tested covaries with disease severity. In this retrospective observational study of hospitalized neurological patients, we derived and validated the FEES Dysphagia Index (FDI) in two temporally independent cohorts (Cohort 1: 2013-2018, N=1,257; Cohort 2: 2021-2025, N=1,686) from a single center. FDI-S averages Penetration-Aspiration Scale (PAS) scores across tested consistencies (0-100 scale); FDI-E uses Yale Pharyngeal Residue scores; FDI-C combines both. Selection bias was quantified using sequential branching-tree inverse probability weighting (IPW). Worst PAS overestimated severity by 24%; FDI deviated by <2%. FDI-C was significantly superior to Worst PAS for hospital-acquired pneumonia (HAP; AUC 0.70 vs. 0.60, p<0.001), mortality (0.71 vs. 0.62, p=0.040), and restricted oral intake (0.90 vs. 0.74, p<0.001), and statistically equivalent to clinician-rated severity. FDI-C mapped linearly onto ordinal Functional Oral Intake Scale values (FOIS; proportional odds RCS p=0.99). With functional status and diagnosis, FDI-C reconstructed the clinician's oral intake recommendation with AUC up to 0.93. The FDI-C-mortality relationship was sigmoidal with a clinically relevant transition zone between ~50 and ~85. FDI-C is a bias-resilient, bedside-calculable score with interval-scale properties that captures expert clinical judgment, suitable as both a clinical decision support tool and a continuous research endpoint.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.